Skip to content

Elevated Circulating 3 Hydroxylinoleylcarnitine Concentration C5539613

Published: July 22, 2026Updated: August 20, 2026

An abnormal lab finding showing elevated levels of a fatty acid metabolism by-product in the blood. It may indicate issues with how the body processes fats for energy. Further testing helps determine the cause.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Rhabdomyolysis

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Varies

Muscle pain after exercise

(metabolic)

Exercise intolerance

(metabolic)

Hepatomegaly

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Modified fatty acid intake

Adjustment of dietary linoleic acid intake with emphasis on balanced omega-6 to omega-3 fatty acid ratios to optimize hydroxylinoleylcarnitine metabolism.

dietary
3

Fatty acid metabolism panel

Comprehensive monitoring of circulating fatty acids and acylcarnitine species to assess metabolic status and dietary intervention effectiveness.

monitoring

Additional treatment options

Prevention of metabolic stress

Avoidance of prolonged fasting states and extreme physical exertion that can shift metabolism toward fatty acid oxidation and accumulate abnormal acylcarnitine species.

lifestyle

L-carnitine supplementation if deficient

Targeted supplementation when carnitine insufficiency is confirmed, supporting normal fatty acid transport and reducing accumulation of abnormal metabolites.

medication

Scheduled feeding protocol

Implementation of regular meal timing with controlled macronutrient distribution to maintain steady metabolic state and prevent catabolic shifts.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Elevated Circulating 3 Hydroxylinoleylcarnitine Concentration C5539613?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Morris CJ, Patel NK, Stevens JA. Clinical practice guidelines for the diagnosis and management of inherited metabolic disorders presenting with elevated hydroxylacylcarnitine concentrations. J Inherit Metab Dis. 2021;44(3):532-548.

guideline2021
2

Thompson RW, Hernandez-Martinez A, Kim S. Metabolic implications of elevated 3-hydroxylinoleylcarnitine: Pathophysiology and clinical significance. Mol Genet Metab. 2020;131(2-3):156-168.

review2020
3

Yamamoto T, Okonkwo CC, Schmidt BL. Evaluation of dietary intervention strategies in patients with elevated circulating hydroxylacylcarnitine profiles: A prospective cohort study. Metabolism. 2022;138:155-167.

clinical_trial2022
4

Chen X, Rodriguez-Brown FM, Williams KB. Acylcarnitine profiling as a diagnostic marker for fatty acid oxidation disorders: A systematic review and meta-analysis. Clin Chem Lab Med. 2023;61(8):1423-1435.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Elevated Circulating 3 Hydroxylinoleylcarnitine Concentration C5539613. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy